Elevance Health, Inc. (ELV) Insider Trading

Last 12 months

Insiders bought $2.24M and sold $1.74M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. EVP & President, Commercial Charles Morgan Kendrick Jr sold $911k on Mar 6, 21% of their stake, outside a plan.

Net open-market

+$493k

3 buys · 5 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

3 / 4

executives and directors

Last open-market buy

Jul 2026

Jul 17, 2026

Get an email when ELV's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 17	Gail Boudreaux President and CEO	Bought 2 parts	2,725	$367.79 average	$1M	1.6%	Form 4
Jul 17	Ramiro G Peru Director	Bought	1,000	$366.05	$366k	10%	Form 4
Jun 12	Ronald W Penczek CAO & Controller	SoldNo plan	369	$403.16	$149k	9.0%	Form 4
Jun 11	Robert L Dixon Jr Director	SoldNo plan	151	$401.77	$61k	1.4%	Form 4
May 19	Ronald W Penczek CAO & Controller	SoldNo plan	1,531	$403.13	$617k	27%	Form 4
Mar 12	Amy W Schulman Director	SoldNo plan	26	$287.50	$7k	11%	Form 4
Mar 6	Charles Morgan Kendrick Jr EVP & President, Commercial	SoldNo plan	3,196	$284.92	$911k	21%	Form 4
Mar 5	Steven H Collis Director	Bought	3,000	$289.84	$870k	469%	Form 4
Aug 19, 2025	Susan D. Devore Director	Bought	1,200	$312.15	$375k	52%	Form 4
Jul 18, 2025	Gail Boudreaux President and CEO	Bought 3 parts	8,500	$286.94 average	$2.44M	6.0%	Form 4
Apr 24, 2025	Mark Kaye EVP & CFO	SoldNo plan	4,588	$424.82	$1.95M	19%	Form 4
Mar 10, 2025	Ronald W Penczek CAO & Controller	SoldNo plan	443	$415.13	$184k	19%	Form 4
Mar 5, 2025	Charles Morgan Kendrick Jr EVP & President, Commercial	SoldNo plan	3,504	$396.30	$1.39M	26%	Form 4

Jul 17
Gail Boudreaux
President and CEO · bought 2,725 at avg $367.79
$1M
1.6% of stake
Jul 17
Ramiro G Peru
Director · bought 1,000 at $366.05
$366k
10% of stake
Jun 12No plan
Ronald W Penczek
CAO & Controller · sold 369 at $403.16
$149k
9.0% of stake
Jun 11No plan
Robert L Dixon Jr
Director · sold 151 at $401.77
$61k
1.4% of stake
May 19No plan
Ronald W Penczek
CAO & Controller · sold 1,531 at $403.13
$617k
27% of stake
Mar 12No plan
Amy W Schulman
Director · sold 26 at $287.50
$7k
11% of stake
Mar 6No plan
Charles Morgan Kendrick Jr
EVP & President, Commercial · sold 3,196 at $284.92
$911k
21% of stake
Mar 5
Steven H Collis
Director · bought 3,000 at $289.84
$870k
469% of stake
Aug 19, 2025
Susan D. Devore
Director · bought 1,200 at $312.15
$375k
52% of stake
Jul 18, 2025
Gail Boudreaux
President and CEO · bought 8,500 at avg $286.94
$2.44M
6.0% of stake
Apr 24, 2025No plan
Mark Kaye
EVP & CFO · sold 4,588 at $424.82
$1.95M
19% of stake
Mar 10, 2025No plan
Ronald W Penczek
CAO & Controller · sold 443 at $415.13
$184k
19% of stake
Mar 5, 2025No plan
Charles Morgan Kendrick Jr
EVP & President, Commercial · sold 3,504 at $396.30
$1.39M
26% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ELV, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Hospital & Medical Service Plans

CNCCentene Corporation

HUMHumana Inc.

CIThe Cigna Group

MOHMolina Healthcare Inc.

UNHUnitedHealth Group Incorporated

PGRProgressive Corporation

METMetLife Inc.

ALLAllstate Corporation

Spot a number that looks wrong? Check it in ELV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ELV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.